Pa ge 1S h ort Title: 
St atistic al A n al ysis Pl a n 
C L K 0 2 7 - P 0 0 1 
F ull Title: 
St atistic al A n al ysis Pl a n 
C L K 0 2 7 - P 0 0 1 / N C T 0 3 1 1 8 9 3 4 
Pr ot oc ol Title: Assessi n g Fitti n g G ui des i n Alc o n M ultif ocal C o ntact Le nses 
Pr oject N u m ber: C L K 0 2 7 - P 0 0 1 
Refer e nce N u m ber: 
Pr ot oc ol T D O C N u m ber: T D O C - 0 0 5 3 4 6 1 
A ut h or: 
Te m pl ate V ersi o n: Ve rsi o n 4. 0, a p pr o ve d 1 6 M A R 2 0 1 5 
A p pr o v als: See last pa ge f or electr o nic a p pr o vals. 
J o b N otes: Alc o n  - B usi ness Use O nl y   Effecti ve D ate:  
D oc u me nt:  Versi o n:  
St at us:  E f f e c t i v e 
Pri nte d B y:  Pri nt Date:  2 . 0 ;  M o s t - R e c e n t ;  E f f e c t i v e ;  C U R R E N T T D O C - [ADDRESS_554890] re visi o n ( V ersi o n 2. 0) Statistical A nal y sis Pla n f or t his st u d y . T his versi o n of 
t he Statistical A nal y sis Pla n is base d o n Ve rsi o n 1. [ADDRESS_554891] u d y  pr ot oc ol. 
Pa ge 2E xec uti ve S u m m ar y: Alc o n  - B usi ness Use O nl y   Effecti ve D ate:  
D oc u me nt:  Versi o n:  
St at us:  E f f e c t i v e 
Pri nte d B y:  Pri nt Date:  2 . 0 ;  M o s t - R e c e n t ;  E f f e c t i v e ;  C U R R E N T T D O C - 0 0 5 3 7 0 1 S t a t i s t i c a l  A n a l y s i s  P l a n 0 7-J u n- 2 0 1 7 
K e y  O bjecti ves: 
To  de m o nstrate n o ni nferi orit y  of t he alter nati ve fitti n g g ui de c o m pare d t o t he c urre nt fitti n g 
g ui de as deter mi ne d b y t he mea n n u m ber of trial le nses nee de d t o fit eac h e y e at t he 
Scree ni n g/ Fitti n g visit f or all Alc o n m ultif ocal ( M F) le nses c o m bi ne d 
Decisi o n Criteria f or St u d y  S uccess: 
S uccess of t his st u d y  will be base d o n de m o nstrati o n of n o ni nferi or mea n n u m ber of trial 
le nses nee de d t o fit eac h e y e of t he alter nati ve fitti n g g ui de c o m pare d t o t he c urre nt fitti n g 
g ui de , at Scree ni n g/ Fitti n g visit f or all Alc o n M F le nses c o m bi ne d .
Pa ge 3Ta ble of C o nte nts Alc o n  - B usi ness Use O nl y   Effecti ve D ate:  
D oc u me nt:  Versi o n:  
St at us:  E f f e c t i v e 
Pri nte d B y:  Pri nt Date:  2 . 0 ;  M o s t - R e c e n t ;  E f f e c t i v e ;  C U R R E N T T D O C - [ADDRESS_554892] of Ta bles 
Ta ble 4 – 1 S u m mar y  of I nfere ntial A nal y sis Strate g y  f or Ef fecti ve ness E n d p oi nts ......... 1 3 
1 4 
Ta ble 1 0 – [ADDRESS_554893] of Fi g ur es Alc o n  - B usi ness Use O nl y   Effecti ve D ate:  
D oc u me nt:  Versi o n:  
St at us:  E f f e c t i v e 
Pri nte d B y:  Pri nt Date:  2 . 0 ;  M o s t - R e c e n t ;  E f f e c t i v e ;  C U R R E N T T D O C - 0 0 5 3 7 0 1 S t a t i s t i c a l  A n a l y s i s  P l a n 0 7-J u n- 2 0 1 7 
Fi g ure 1 – [ADDRESS_554894] u d y O bjecti ves 
P RI M A R Y O B J E C TI V E 
To de m o nstrate n o ni nferi orit y of t he alter nati ve fitti n g g ui de c o m pare d t o t he c urre nt fitti n g Alc o n  - B usi ness Use O nl y   Effecti ve D ate:  
D oc u me nt:  Versi o n:  
St at us:  E f f e c t i v e 
Pri nte d B y:  Pri nt Date:  2 . 0 ;  M o s t - R e c e n t ;  E f f e c t i v e ;  C U R R E N T T D O C - 0 0 5 3 7 0 1 S t a t i s t i c a l  A n a l y s i s  P l a n 0 7-J u n- 2 0 1 7 
g ui de as deter mi ne d b y t he mea n n u m ber of trial le nses nee de d t o fit eac h e y e at t he 
Scree ni n g/ Fitti n g visit f or all Alc o n M F le nses c o m bi ne d 
Pa ge 61. [ADDRESS_554895] -mas ke d, ra n d o mize d, parallel, stratifie d, acti ve -c o ntr olle d 
e val uati o n t o c o m pare t he fitti n g s uccess ( deter mi ne d b y  t he mea n n u m ber of trial le nses 
nee de d t o s uccessf ull y fit eac h e y e) usi n g t he c urre nt M F fitti n g g ui de c o m pare d t o t he 
alter nati ve M F fitti n g g ui de f or all t hree of t he Alc o n M F c o ntact le nses ( AI R O P TI X 
A Q U A ®M ultif ocal [ A O A  M F], D AI LI E S ®A q ua C o mf ort Pl us ®M ultif ocal [ D A C P  M F], a n d 
D AI LI E S T O T A L 1 ®Alc o n  - B usi ness Use O nl y   Effecti ve D ate:  
D oc u me nt:  Versi o n:  
St at us:  E f f e c t i v e 
Pri nte d B y:  Pri nt Date:  2 . 0 ;  M o s t - R e c e n t ;  E f f e c t i v e ;  C U R R E N T T D O C - 0 0 5 3 7 0 1 S t a t i s t i c a l  A n a l y s i s  P l a n 0 7-J u n- 2 0 1 7 
M ultif ocal [ D T 1 M F]). 
A p pr o xi matel y  [ADDRESS_554896] le ns wearers nee di n g pres b y o pia -c orrecti o n, wit h 
a near s pectacle A D D of + 0. 5 0 D t o + 2. 5 0 D (i ncl usi ve) . Eac h site will e nr oll a p pr o xi matel y  
9 s u bjects ( 6 will be m o nt hl y/ wee kl y ha bit ual le ns wearers a n d 3 will be dail y  dis p osa ble 
ha bit ual le ns wearers).  
 
 
Ra n d o mizati o n f or t his st u d y  will be i m ple me nte d i n [ADDRESS_554897], eac h site will be 
ra n d o mize d t o o ne fitti n g g ui de a n d will fit all s u bjects at t heir site usi n g t he assi g ne d fitti n g 
g ui de (c urre nt or alter nati ve). T he p ur p ose of t his strate g y  is t o re d uce t he li keli h o o d t hat 
err ors will b e ma de i n fitti n g t he trial le nses if tr y i n g t o use t w o si milar fitti n g g ui des. 
Ra n d o mizati o n of t he fitti n g g ui de will be stratifie d b y  re gi o n .
Sec o n dl y , s u bjects w h o c urre ntl y wear m o nt hl y/ wee kl y c o ntact le nses will be ra n d o mize d t o 
eit her A O A  M F or D A C P M F c o ntact le nses ( 1: 1 ra n d o mizati o n).  S u bjects w h o c urre ntl y  
wear dail y  dis p osa ble c o ntact le nses will be fitte d wit h D T [ADDRESS_554898] u d y  is 1 0 ± 3 da y s ( 7 da y s mi ni m u m) 
a n d u p t o 3 3 da y s ( m a xi m u m) f or all s u bjects wit h a mi ni m u m of 2 sc he d ule d visits, u p t o 5 
sc he d ule d visits, de pe n di n g o n necessit y of refit dis pe nsi n g a n d f oll o w- u p visits .T he s t u d y  
desi g n is prese nte d i n Fi g ure 1 – 1. 
Pa ge 7Fi g ur e 1 – 1 St u d y Desi g n 
Vi si t 1
Sc r e e n i n g / Fi tt i n g  Vi si t
Vi si t [ADDRESS_554899]  L e ns  D is p e ns i n g  Vi si t0- 7 D a ys 
Vi si t 3 F o ll o w U p 1
Pr es cr i pt i o n o p ti mi z a ti o n  r e q u ir e d ?1 0 ± [ADDRESS_554900] u d y l e n s e s
1 0 ± 3 d a ys 
Vi si t 3 E x it 
Pr es cr i p ti o n  o pti mi z a ti o n  r e q u ir e d ?N O 
Y E S
As s e ss o p ti m a l pr es cr i pt i o n  a n d 
E x it S u bj ec t
1. 3 R a n d o miz ati o n Alc o n  - B usi ness Use O nl y   Effecti ve D ate:  
D oc u me nt:  Versi o n:  
St at us:  E f f e c t i v e 
Pri nte d B y:  Pri nt Date:  2 . 0 ;  M o s t - R e c e n t ;  E f f e c t i v e ;  C U R R E N T T D O C - [ADDRESS_554901], c o ntai ni n g a car d wit h t he 
Pa ge 8res pecti ve fitti n g g ui de t o use. S u bse q ue ntl y , ra n d o mizati o n f or ha bit ual wee kl y/ m o nt hl y le ns 
wearers will be i m ple me nte d. 
1. [ADDRESS_554902] -mas ke d. S u bjects are mas ke d o nl y  t o t he M F fitti n g g ui des. 
1. 5 I nteri m A n al ysis 
N ot a p plica ble .
2 A n al ysis Sets 
2. 1 S afet y A n al ysis Set 
Safet y  a nal ys es will be c o n d ucte d usi n g t he safet y a nal ys is set o n a treat me nt -e mer ge nt basis. 
As s uc h, t he safet y  a nal ysis set will i ncl u de all s u bjects/e yes e x p o se d t o st u d y  le nses 
e val uate d i n t his st u d y , e xce pt f or t he trial le nses use d f or para metrizati o n a n d fitti n g at V isit 
1. F or treat me nt -e mer ge nt safet y a nal ys es, s u bjects/e y es will be cate g orize d u n der t he act ual 
st u d y  le nses e x p ose d. 
S u bjects w h o are l ost t o f oll o w -u p a n d t heir e x p os ure t o dis pe nse d st u d y le nses is u n k n o w n 
will be i ncl u de d i n t he safet y  data set. T he dis pe nse date f or t hese s u bjects will be ass u me d as 
t he first e x p os ure date ( V isit 2 Dis pe nse 1) .
2. 2 F ull A n al ysis Set 
T he F ull A nal ys is Set ( F A S) will i ncl u de :
1. all ra n d o mize d s u bjects t o A O A  M F or D A C P M F as well as s u bjects assi g ne d t o D T [ADDRESS_554903] u d y le nses i ncl u di n g t h ose use d f or para metrizati o n a n d fitti n g 
at V isit 1 
All ef fecti ve ness a nal ys es rele va nt t o fi tti n g g ui de will be c o n d ucte d acc or di n g t o t he 
ra n d o mize d assi g n me nt. Ef fecti ve ness a nal y ses base d u p o n le ns bra n d will be c o n d ucte d 
acc or di n g t o t he ra n d o mize d or n o n -ra n d o mize d assi g n me nt as a p plica ble t o t he ha bit ual le ns 
wear. 
2. 3 Per Pr ot oc ol A n al ysis Se tAlc o n  - B usi ness Use O nl y   Effecti ve D ate:  
D oc u me nt:  Versi o n:  
St at us:  E f f e c t i v e 
Pri nte d B y:  Pri nt Date:  2 . 0 ;  M o s t - R e c e n t ;  E f f e c t i v e ;  C U R R E N T T D O C - 0 0 5 3 7 0 1 S t a t i s t i c a l  A n a l y s i s  P l a n 0 7-J u n- 2 0 1 7 
T he Per Pr ot oc ol ( P P) A nal y sis Set will i ncl u de :
Pa ge 91. all ra n d o mize d s u bjects t o A O A  M F or D A C P M F as well as s u bjects assi g ne d t o D T 1 
M F a n d 
2. all data/s u bjects w hic h ha ve n ot  met a n y of t he critical de viati o n or n o n -e val ua ble 
criteria i de ntifie d i n t he D e via ti o ns a n d Eval ua bilit y  P la n 
All ef fecti ve ness a nal ys es rele va nt t o f itti n g g ui de will be c o n d ucte d acc or di n g t o t he 
ra n d o mize d assi g n me nt. Ef fecti ve ness a nal y ses base d u p o n le ns bra n d will be c o n d ucte d 
acc or di n g t o t he ra n d o mize d or n o n -ra n d o mize d assi g n me nt as a p plica ble t o t he ha bit ual le ns 
wear. 
[ADDRESS_554904] S u m m aries 
De m o gra p hic i nf or mati o n ( a ge, se x, et h nicit y , a n d race ) will be s u m mar ize d o n t he safet y, 
f ull a n d P P a nal y sis set s. Baseli ne c haracteristics o n ha bit ual le ns  
 will be s u m marize d o n t he 
f ull a n d P P  a nal y sis sets . . 
All descri pti ve s u m mar y  statistics will be dis pla y e d wit h c o u nts a n d perce nta ge f or 
cate g orical data, a n d wit h n, mea n, sta n dar d de viati o n, me dia n, mi ni m u m, a n d ma xi m u m f or 
c o nti n u o us data. 
4 Effecti ve ness A n al ysis Str ate g y Alc o n  - B usi ness Use O nl y   Effecti ve D ate:  
D oc u me nt:  Versi o n:  
St at us:  E f f e c t i v e 
Pri nte d B y:  Pri nt Date:  2 . 0 ;  M o s t - R e c e n t ;  E f f e c t i v e ;  C U R R E N T T D O C - [ADDRESS_554905] u d y  defi nes o ne pri mar y  e n d p oi nt, 
. All ef fecti ve ness e val uati o ns will use t he F A S as t he pri mar y  a nal ys is 
set. S u p p orti ve a nal ys es of t he pri mar y   effecti ve ness e n d p oi nt will be 
c o n d ucte d usi n g t he P P  a nal y sis set o nl y if t he n u m ber of s u bj ects e xcl u de d fr o m P P  a nal ys is 
set e xcee ds 5 % of F A S. A s u m mar y  of t he pla n ne d a nal ys is strate g y  is prese nte d i n Ta ble 4 – 1 
S u m mar y  of I nfere ntial A nal y sis Strate g y  f or Ef fecti ve ness E n d p oi nts . 
F or all pla n ne d i nfere ntial a nal y ses, alter nati ve m o dels/ met h o ds ma y  be c o nsi dere d if 
c o n ver ge nce ca n n ot be ac hie ve d .
 
 
 
Pa ge 1 0 2.  
 
4. 1 Effecti ve ness E n d p oi nts 
Pri m ar y E n d p oi nt Alc o n  - B usi ness Use O nl y   Effecti ve D ate:  
D oc u me nt:  Versi o n:  
St at us:  E f f e c t i v e 
Pri nte d B y:  Pri nt Date:  2 . 0 ;  M o s t - R e c e n t ;  E f f e c t i v e ;  C U R R E N T T D O C - 0 0 5 3 7 0 1 S t a t i s t i c a l  A n a l y s i s  P l a n 0 7-J u n- 2 0 1 7 
T he pri mar y  e n d p oi nt is t he n u m ber of trial le nses nee de d t o fit eac h e y e at t he 
Scree ni n g/ Fitti n g visit ( V isit 1) , deri ve d fr o m n u m ber of o n -e y e le ns prescri pti o n s. 
Pa ge 1 1 4. 2 Effecti ve ness H y p ot heses 
4. 2. 1 H y p ot hesis f or t he Pri m ar y E n d p oi nt 
T he pri mar y  h y p ot hesis t o be teste d is t he n o ni nferi orit y  of t he alter nati ve fitti n g g ui de w he n 
c o m pare d t o t he c urre nt fitti n g g ui de i n fitti n g . T he n ull a n d alter nati ve h y p ot he ses are 
f or m ulate d base d o n a pre -defi ne d n o ni nferi orit y mar gi n of 0 . 5 as f oll o ws : 
H0: µ ( A F G) –µ( C F G) ≥ 0. 5 
Ha: µ ( A F G) – µ ( C F G) < 0. 5 
w here µ( A F G) a n d µ( C F G) de n ote t he mea n n u m ber of trial le nses use d t o ac hie ve fit i n eac h e y e 
usi n g t he alter nati ve a n d c urre nt fitti n g g ui de, res pecti vel y , at t he Scree ni n g/ Fitti n g visit. All 
Alc o n M F le nses are t o be i ncl u de d. 
4. [ADDRESS_554906] t hese h y p ot heses, i ncl u di n g 
ter ms f or fitti n g g ui de,  
 C orrelati o n bet wee n e y es will be acc o u nte d f or . Fitti n g g ui de 
dif fere nce ( Alter nati ve mi n us C urre nt) a n d t he c orres p o n di n g o ne- si de d 9 5 % u p per 
c o nfi de nce li mit ( U C L ) will be c o m p ute d. N o ni nferi orit y i n fit ti n g will be declare d if U C L  < 
0. 5 at V isit 1. T he foll o wi n g S A S pse u d o c o de will be use d f or t he a nal ys is :
pr oc s ort d at a = o ne ; by s u bject; r u n; Alc o n  - B usi ness Use O nl y   Effecti ve D ate:  
D oc u me nt:  Versi o n:  
St at us:  E f f e c t i v e 
Pri nte d B y:  Pri nt Date:  2 . 0 ;  M o s t - R e c e n t ;  E f f e c t i v e ;  C U R R E N T T D O C - 0 0 5 3 7 0 1 S t a t i s t i c a l  A n a l y s i s  P l a n 0 7-J u n- 2 0 1 7 
pr oc mixe d d at a =o ne ;
Pa ge [ADDRESS_554907] fitti n g _ g ui de le ns A D D _ p o wer re gi o n eye ;
     m o del y= fitti n g _ g ui de le ns fitti n g _ g ui de *le ns re gi o n A D D _ p o wer / d df m = kr ;
     re pe ate d eye /s u bject =s u bject ty pe = (t o be deter mi ne d) ;
     ls me a ns fitti n g _ g ui de / cl diff al p h a = 0. 1 0 e; Alc o n  - B usi ness Use O nl y   Effecti ve D ate:  
D oc u me nt:  Versi o n:  
St at us:  E f f e c t i v e 
Pri nte d B y:  Pri nt Date:  2 . 0 ;  M o s t - R e c e n t ;  E f f e c t i v e ;  C U R R E N T T D O C - 0 0 5 3 7 0 1 S t a t i s t i c a l  A n a l y s i s  P l a n 0 7-J u n- 2 0 1 7 
r u n ;
Pa ge 1 3 Ta ble 4 – 1 S u m m ar y of I nfer e nti al A n al ysis Str ate g y f or  Effecti ve ness 
E n d p oi nts 
E n d p oi nt Mai n vs. 
Se nsiti vit y  
A p pr oac h aStatistical 
Met h o dbA nal y sis Set Missi n g Data 
A p pr oac h 
Pri m ar y 
N u m ber of le nses 
nee de d f or fit at 
Visit 1 M Li near mi xe d 
m o del cF A S (as 
ra n d o mize d) O bser ve d 
data o nl y 
N u m ber of le nses 
nee de d f or fit at S Li near mi xe d P P S (as O bser ve d Alc o n  - B usi ness Use O nl y   Effecti ve D ate:  
D oc u me nt:  Versi o n:  
St at us:  E f f e c t i v e 
Pri nte d B y:  Pri nt Date:  2 . 0 ;  M o s t - R e c e n t ;  E f f e c t i v e ;  C U R R E N T T D O C - 0 0 5 3 7 0 1 S t a t i s t i c a l  A n a l y s i s  P l a n 0 7-J u n- 2 0 1 7 
Pa ge 1 4 Visit 1 m o del cra n d o mize d) data o nl y 
aM = Mai n a nal ysis a p pr oac h; S = Se nsiti vit y a nal ysis a p pr oac h 
bF urt her details o n statistical m o dels are: 
  
 Alc o n  - B usi ness Use O nl y   Effecti ve D ate:  
D oc u me nt:  Versi o n:  
St at us:  E f f e c t i v e 
Pri nte d B y:  Pri nt Date:  2 . 0 ;  M o s t - R e c e n t ;  E f f e c t i v e ;  C U R R E N T T D O C - 0 0 5 3 7 0 1 S t a t i s t i c a l  A n a l y s i s  P l a n 0 7-J u n- 2 0 1 7 
Pa ge 1 5 4. 4 M ulti plicit y Str ate g y 
A se q ue ntial gate kee pi n g strate g y  will be i m ple me nte d t o c o ntr ol testi n g of m ulti ple 
eff ecti ve ness e n d p oi nts. T heref ore, t he o verall t y p e I err or will be c o ntr olle d at o ne -si de d 
0. 0 5 wit h t he f oll o wi n g testi n g or der: 
N o ni nferi orit y of pri mar y  e n d p oi nt 
4. 6 I nteri m A n al ysis f or  Effecti ve ness 
N o t a p plica ble .
5 S afet y A n al ysis Str ate g y 
5. 1 S afet y E n d p oi nts 
T he safet y e n d p oi nts are 
 A d verse e ve nts 
 Bi o micr osc o p y fi n di n gs 
oLi m bal h y pere mia 
oB ul bar h y pere mia 
oOt her fi n di n gs 
 De vice deficie ncies 
5. [ADDRESS_554908] atistic al Met h o ds f or S afet y A n al yses Alc o n  - B usi ness Use O nl y   Effecti ve D ate:  
D oc u me nt:  Versi o n:  
St at us:  E f f e c t i v e 
Pri nte d B y:  Pri nt Date:  2 . 0 ;  M o s t - R e c e n t ;  E f f e c t i v e ;  C U R R E N T T D O C - 0 0 5 3 7 0 1 S t a t i s t i c a l  A n a l y s i s  P l a n 0 7-J u n- 2 0 1 7 
T he a nal ys is set f or all safet y  a nal ys es is t he safet y a nal ys is set as defi ne d i n Secti o n 2. 1. 
Safet y  varia bles will be s u m marize d descri pti vel y .
Pa ge 1 6 5. 3. 1 A d verse E ve nts 
T he a p plica ble defi niti o n of a n A d verse E ve nt ( A E) is i n t he st u d y pr ot oc ol. All A Es 
occ urri n g fr o m w he n a s u bject si g ns i nf or me d c o n se nt t o w he n a s u bject e xits t he st u d y  will 
be acc o u nte d f or i n t he re p orti n g. 
A nal y sis a n d prese ntati o n of pre -treat me nt a n d bet wee n -treat me nt A Es will be se parate d fr o m 
treat me nt -e mer ge nt A Es occ urri n g d uri n g t he st u d y  peri o d. A pre -treat me nt A E is a n e v e nt 
t hat occ urs after si g ni n g i nf or me d c o nse nt b ut pri or t o e x p os ure t o st u d y  le ns n ot use d f or 
le ns para metrizati o n a n d fitti n g at V isit 1. A bet wee n -treat me nt A E is a n e ve nt t hat occ urs 
after last e x p os ure t o dis pe nse [ADDRESS_554909] u d y  le ns dis pe nse d at 
Vi sit 2 ( Dis pe nse 1) u ntil t he s u bject c o m pletes or is disc o nti n ue d fr o m t he st u d y , e xcl u di n g 
t he bet we e n -treat me nt peri o d. 
Descri pti ve s u m maries (c o u nts a n d perce nta ges) f or oc ular a n d n o n oc ular treat me nt -e mer ge nt 
A Es will be prese nte d b y Me dical Dicti o nar y f or Re g ulat or y Acti vities ( Me d D R A) S y ste m 
Or ga n Class ( S O C) a n d Preferre d T er ms ( P T). Seri o us A Es w ill be s u m marize d se paratel y.  
A d diti o nall y , relati o ns hi p t o le ns will be i de ntifie d i n all A E ta bles . U nit of p rese ntati o n f or 
oc ular A Es will be e y es a n d n o n oc ular A Es will be s u bjects. 
I n di vi d ual s u bject’ s listi n gs will be pr o vi de d f or pre -treat me nt , be t wee n -treat me nt a n d 
treat me nt e mer ge nt A Es , w here a n y  A E lea di n g t o st u d y  disc o nti n uati o n will be i n dicate d. 
5. 3. 2 Bi o micr osc o p y Fi n di n gs Alc o n  - B usi ness Use O nl y   Effecti ve D ate:  
D oc u me nt:  Versi o n:  
St at us:  E f f e c t i v e 
Pri nte d B y:  Pri nt Date:  2 . 0 ;  M o s t - R e c e n t ;  E f f e c t i v e ;  C U R R E N T T D O C - [ADDRESS_554910] u d y  visits, i ncl u di n g sc he d ule d visits 
a n d u nsc he d ule d visits . If V isit 1 a n d V isit 2 Dis pe nse 1 occ ur o n t he sa me da y , 
bi o micr osc o p y  will o nl y  be perf or me d o nce at t he visit. Si milarl y , if Vi sits 3 F oll o w -u p 1 a n d 
Vi sit 2 Dis pe nse 2 occ ur o n t he sa me da y . T he re p orti n g u nit f or eac h bi o micr osc o p y  fi n di n g 
will be e y es . A s u m mar y  of gra de cate g or y  c o u nts a n d perce nta ges will be prese nte d f or eac h 
para meter b y visit. A s hift ta ble s h o wi n g gra de at baseli ne relati ve t o f oll o w -u p visits will be 
prese nte d b y visit f or eac h para meter . Baseli ne will be defi ne d as Vi sit 2, e xce pt if V isit 2 
occ urs o n t he sa me da y  as Vi sit 1, Baseli ne will be o btai ne d fr o m V isit 1. 
F or eac h bi o micr osc o p y para meter , c o u nts a n d perce nta ges of e y es w hic h e x perie nce a n 
i ncrease of ≥ 2 gra des fr o m baseli ne t o a n y s u bse q ue nt visit (i ncl u di n g u nsc he d ule d v isits) 
will be prese nte d. A listi n g will be pr o vi de d w hic h prese nts all e y es wit h a n i ncrease of ≥ [ADDRESS_554911] u d y  pr ot oc ol. A fre q ue n c y  ta ble 
s h o wi n g c o u nts f or eac h De vice Deficie nc y  cate g or y  will be prese nte d. I n a d diti o n, listi n g s
f or treat me nt -e mer ge nt a n d pre -treat me nt ( pri or t o e x p os ure t o st u d y  le nses n ot use d f or le ns 
para metrizati o n a n d fitti n g at V isit 1) de vice deficie ncies will be pr o vi de d. 
6 A n al ysis Str ate g y f or Ot her E n d p oi nts 
N ot a p plica ble .
7 S a m ple Size a n d P o wer C alc ul ati o ns 
Sa m ple size calc ulati o n f or t he pri mar y  ef fecti ve ness h y p ot hesis o n fit s uccess is base d o n 
res ults  Wi t h a n ass u me d c o m m o n sta n dar d de viati o n of 0. 6 a n d 
e x pecte d dif fere nce of 0. 2 5, a sa m ple size of 8 0 ( 1 6 0 e y es) i n eac h gr o u p will pr o vi de 8 3 % 
p o wer f or a n o ni nferi orit y mar gi n of 0. 5, at o ne -si de d α = 0. [ADDRESS_554912] re visi o n ( V ersi o n 2. 0) Statistical A nal y sis Pla n f or t his st u d y . T his versi o n of 
t he Statistical A nal y sis Pla n is base d o n Ve rsi o n 1. [ADDRESS_554913] u d y  pr ot oc ol. Alc o n  - B usi ness Use O nl y   Effecti ve D ate:  
D oc u me nt:  Versi o n:  
St at us:  E f f e c t i v e 
Pri nte d B y:  Pri nt Date:  2 . 0 ;  M o s t - R e c e n t ;  E f f e c t i v e ;  C U R R E N T T D O C - 0 0 5 3 7 0 1 S t a t i s t i c a l  A n a l y s i s  P l a n 0 7-J u n- 2 0 1 7 
S u m mar y  of c ha n ges: 
-To  u p date t he defi niti o n of safet y a nal ys is set i n or der t o i ncl u de s u bj ects w h o are l ost 
t o f oll o w -u p a n d t heir e x p os ure t o dis pe nse d st u d y  le nses is u n k n o w n 
Pa ge 1 8 Ite mize d C ha n ges: 
Secti o n I nf or m ati o n C h a n ge d 
Secti o n 2. 1 T he f oll o wi n g was a d de d: 
S u bjects w h o are l ost t o f oll o w -u p a n d t heir e x p os ure t o 
dis pe nse d st u d y  le nses is u n k n o w n will be i ncl u de d i n t he 
safet y data set. T he dis pe nse date f or t hese s u bjects will be 
ass u me d as t he first e x p os ure date ( V isit 2 Dis pe nse 1). Alc o n  - B usi ness Use O nl y   Effecti ve D ate:  
D oc u me nt:  Versi o n:  
St at us:  E f f e c t i v e 
Pri nte d B y:  Pri nt Date:  2 . 0 ;  M o s t - R e c e n t ;  E f f e c t i v e ;  C U R R E N T T D O C - 0 0 5 3 7 0 1 S t a t i s t i c a l  A n a l y s i s  P l a n 0 7-J u n- 2 0 1 7 
Pa ge 1 9 1 0 A p pe n di x 
Ta ble 1 0 – [ADDRESS_554914] a n 
Visit 1 Visit 2 Dis pe nse 1 
/ Visit 2 Dis pe nse 
2Visit 3 
F oll o w U p 
1 / Visit 3 
E xit U S V 
Pr oce d ure/ Assess me nt Scree ni n g 
a n d Fitti n g Dis pe nsi n g 
0- 7 d a ys fr o m 
Visit 1  D a y 1 0 ± 3 
–F oll o w -
u p / E xit U nsc he d ule d 
Visit 
Ra n d o mizati o n 
Site t o Fitti n g G ui de *
I n f or me d C o nse nt 
De m o gra p hics 
Me dical Hist or y  
C o nc o mita nt Me dicati o ns/ C ha n ges i n 
C o nc o mita nt Me dicati o ns    
S u bjecti ve ( Ma nifest) refracti o n  () () ( )
B C V A †( wit h ma nifest refracti o n)  () () ( )Alc o n  - B usi ness Use O nl y   Effecti ve D ate:  
D oc u me nt:  Versi o n:  
St at us:  E f f e c t i v e 
Pri nte d B y:  Pri nt Date:  2 . 0 ;  M o s t - R e c e n t ;  E f f e c t i v e ;  C U R R E N T T D O C - [ADDRESS_554915] le ns para meters 
o pti mizati o n a n d fitti n g † 
I n cl usi o n/ E xcl usi o n 
Ra n d o mizati o n 
Wee kl y / M o nt hl y  S u bject t o st u d y  le ns * * 
Dis pe nse st u d y  le nses * * 
Bi o micr osc o p y    
Assess o pti mal prescri pti o n e()
Assess A Es f  
Assess de vice deficie ncies    
E xit F or m () ()  ()
A E = A d verse E ve nt; B C V A = Best C orrecte d Vis ual Ac uit y; l o g M A R = l o garit h mic Mi ni m u m A n gle of Res ol uti o n; U S V 
= U nsc he d ule d Visit; V A = Vis ual Ac uit y 
If s u bject nee ds a ne w prescri pti o n, perf or m Visit 2 Dis pe nse 2 a n d Visit 3/ E xit 
fA E s are c ollecte d fr o m t he ti me of i nf or me d c o nse nt 
 
(Alc o n  - B usi ness Use O nl y   Effecti ve D ate:  
D oc u me nt:  Versi o n:  
St at us:  E f f e c t i v e 
Pri nte d B y:  Pri nt Date:  2 . 0 ;  M o s t - R e c e n t ;  E f f e c t i v e ;  C U R R E N T T D O C - 0 0 5 3 7 0 1 S t a t i s t i c a l  A n a l y s i s  P l a n 0 7-J u n- 2 0 1 7 
) as nee de d, or if a 2- li ne c ha n ge i n c o ntact le ns c orrecte d V A is o bser ve d ( Ma nifest refracti o n a n d B C V A o nl y) 
* Pri or t o Visit 1 
* * per ra n d o mizati o n sc he me , if wee kl y/ m o nt hl y le ns wearers     
  
† S o urce o nl y 
                                                                                                                
                                                                                     
D at e/ Ti m e 
( m m/ d d/ y y y y G M T): Si g n e d b y: J u stifi c ati o n :C D M A L e a d 
L E M P J E 1 0 6/ 0 5/ 2 0 1 7 2 0: 4 3: 4 7 J e s si e L e m p 
Alc o n  - B usi ness Use O nl y   Effecti ve D ate:  
D oc u me nt:  Versi o n:  
St at us:  E f f e c t i v e 
Pri nte d B y:  Pri nt Date:  2 . 0 ;  M o s t - R e c e n t ;  E f f e c t i v e ;  C U R R E N T T D O C - 0 0 5 3 7 0 1 S t a t i s t i c a l  A n a l y s i s  P l a n 0 7-J u n- 2 0 1 7 